Clinical Trial Update: Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase, open-label, single-arm clinical trial evaluating intrathecal methotrexate in patients with progressive multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Methotrexate (intrathecal) (Methotrexate)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: To Evaluate the Effect of Therapy With IT MTX on the Disease Course of Patients With Progressive MS | EARLY_Phase 1 | Status: UNKNOWN